Global Rheumatoid Arthritis Drug Market Is Ruled by Top 5 DMARDs, Says Kuick Research in New Report Available at MarketPublishers.com
22 Mar 2017 • by Natalie Aster
LONDON – There are 5 DMARDs that dominate the global anti-rheumatics marketplace, and their total revenue stood at over USD 25 billion as of 2016. These drugs are unlikely to be dethroned in the near term, though the competition from biosimilars is set to increase.
The treatment paradigm of rheumatoid arthritis has changed substantially over the last few decades. Now the paradigm aimed at the slowdown of the disease progression and even its remission, while it used to focus on symptom management.
Disease modifying biological medicines played substantial role in this transformation. The global anti-rheumatics marketplace is set to showcase constant growth in the coming years. The rising number of patients suffering from rheumatoid arthritis, an increase in R&D activities, the rising awareness about the disease, and more.
There have been a number of important developments in the treatment space, including the introduction of a new class of small-molecule anti-inflammatory compounds that target signal transduction molecules.
Still, biomarkers helping to diagnose the disease at early stages are the most valuable development in this space.
New research report “Global Rheumatoid Arthritis Drug Market Outlook 2022” drawn up by Kuick Research offers a comprehensive discussion of the global market for rheumatoid arthritis drugs. The study starts with a detailed overview of the disease.
It outlines the molecular mechanism of antirheumatoids. The report classifies rheumatoid arthritis drugs. The research study sheds light on the treatment landscape and concentrates on major drugs.
It discusses the global prevalence of the disease. The research report proceeds with an all-round overview of the marketplace. The study scrutinizes the market dynamics and sheds light on future prospects of the space. Top companies are also looked at in the report.
- insightful discussion of the market performance;
- coverage of the market dynamics;
- insights into the competitive environment;
- information on top players;
- future outlook;
- and more.
More new reports by Kuick Research can be found at its page.